ApoC-II as a Regulator of Lipoprotein Metabolism in Women: Understanding Dyslipidemia as a Cardiovascular Risk Factor

    StatusFinished
    Effective start/end date1/01/1331/12/13

    Funding

    • Royal Perth Hospital Medical Research Foundation